Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Exosome-mediated intercellular signaling is a complex, physiological and pathological process in which exosomes, 30–150 nm extracellular vesicles derived from the endosomal compartment, facilitate cell-to-cell communication by transferring proteins, lipids, and nucleic acids (including mRNA, miRNA, and DNA) from donor to recipient cells. Exosome biogenesis involves the formation of multivesicular bodies, and exosome release occurs following fusion with the plasma membrane. Exosomes are implicated in regulating immune responses, carrying tumor markers, modulating gene expression, and contributing to the tumor microenvironment, inflammation, and other diseases. Because "exosome-mediated signaling" refers to an overall communication mechanism involving many molecular and cellular components, it is not a discrete molecular target.
Not applicable; therapies may exploit exosomes for delivery or modulate their release, but no drugs target "exosome-mediated signaling" as a molecular entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Exosome-mediated intercellular signaling (null).